GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Ending Cash Position

Inventage Lab (XKRX:389470) Ending Cash Position : ₩0.0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Ending Cash Position?

Inventage Lab's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩0.0 Mil.

Inventage Lab's quarterly Ending Cash Position declined from Sep. 2023 (₩18,558.9 Mil) to Dec. 2023 (₩18,481.9 Mil) and declined from Dec. 2023 (₩18,481.9 Mil) to Mar. 2024 (₩0.0 Mil).

Inventage Lab's annual Ending Cash Position declined from Dec. 2021 (₩19,256.1 Mil) to Dec. 2022 (₩15,781.0 Mil) but then increased from Dec. 2022 (₩15,781.0 Mil) to Dec. 2023 (₩18,481.9 Mil).

Inventage Lab Ending Cash Position Historical Data

The historical data trend for Inventage Lab's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Ending Cash Position Chart

Inventage Lab Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
3,928.00 11,930.19 19,256.13 15,780.96 18,481.91

Inventage Lab Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,262.61 25,077.23 18,558.93 18,481.91 -

Inventage Lab Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Inventage Lab's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=15780.965+2700.949
=18,481.9

Inventage Lab's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.0

Inventage Lab Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Inventage Lab's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Inventage Lab (XKRX:389470) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Ending Cash Position
Comparable Companies
XKRX:003120 XKRX:061250 XKRX:006620 XKRX:330350 XKRX:054670 XKRX:000230 XKRX:063160 XKRX:067290 XKRX:002210 XKRX:183490 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403
Website
https://www.inventagelab.com
Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines